These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2869819)
1. Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease. Bowen DM; Davison AN Br Med Bull; 1986 Jan; 42(1):75-80. PubMed ID: 2869819 [No Abstract] [Full Text] [Related]
5. An update on the neurochemistry of Alzheimer disease. Davies P Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134 [No Abstract] [Full Text] [Related]
6. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type. Davies P Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427 [No Abstract] [Full Text] [Related]
8. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease. Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697 [TBL] [Abstract][Full Text] [Related]
9. Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism. Najlerahim A; Bowen DM Biochem J; 1988 Apr; 251(1):305-8. PubMed ID: 3390157 [TBL] [Abstract][Full Text] [Related]
10. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease. Yates CM; Simpson J; Gordon A Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479 [TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease and the new neuroscience. Wortis J Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248 [No Abstract] [Full Text] [Related]
12. Neurotransmitters and second messengers in aging and Alzheimer's disease. Francis PT; Webster MT; Chessell IP; Holmes C; Stratmann GC; Procter AW; Cross AJ; Green AR; Bowen DM Ann N Y Acad Sci; 1993 Sep; 695():19-26. PubMed ID: 7902054 [TBL] [Abstract][Full Text] [Related]
13. The metabolism of some neurotransmitters in ageing and dementia disorders. Gottfries CG Gerontology; 1982; 28 Suppl 2():11-9. PubMed ID: 6131853 [No Abstract] [Full Text] [Related]
15. Significance of neurotransmitter abnormalities in Alzheimer's disease. Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637 [No Abstract] [Full Text] [Related]
16. Choline in Alzheimer's disease. Spillane JA; Goodhart MJ; White P; Bowen DM; Davison AN Lancet; 1977 Oct; 2(8042):826-7. PubMed ID: 71636 [No Abstract] [Full Text] [Related]
17. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256 [TBL] [Abstract][Full Text] [Related]
18. [Neurotransmitter abnormalities in the dementia of Alzheimer type]. Sasaki H; Arai H Rinsho Shinkeigaku; 1986 Dec; 26(12):1290-3. PubMed ID: 2881639 [No Abstract] [Full Text] [Related]
20. Biochemical changes in the cholinergic system of the ageing brain and in senile dementia. Bowen DM; Davison AN Psychol Med; 1980 May; 10(2):315-9. PubMed ID: 6104344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]